在心房动中使用多菲提利德:综合性综述
Diksha Mahendru1, Harin D Joshi2, Peter Kowey3
1Division of Internal Medicine, Lankenau Medical Center, Wynnewood, PA, USA.
Indian pacing and electrophysiology journal
|November 30, 2025
概括
多菲提利德通过选择性地阻断电流来有效控制心房动 (AF) 节律. 虽然对于心脏病患者来说是安全的,但由于潜在的副作用,其使用需要仔细监测.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心房动 (AF) 是一种普遍的心律失常,对全球健康产生重大影响.
- 管理AF涉及复杂的策略,包括速度/节律控制,抗凝血和并发症管理.
研究的目的:
- 为提供对dofetilide的全面审查,dofetilide是一种III类抗心律失常药物.
- 分析多菲提利德的药理学,临床证据,安全性和指导方针建议.
主要方法:
- 对多菲提利德的特性和临床应用的文献综述.
- 分析临床试验数据和安全概况.
- 审查指导方针建议和特殊的人口考虑.
主要成果:
- 多菲提利德选择性地阻断IKr电流,提供节律控制与最小的负性内托普.
- 它的安全性对结构性心脏病和左心室功能障碍患者有利.
- 担忧包括torsades de pointes的风险,需要在医院启动和严格监测.
结论:
- 多菲提利德是AF节律控制的有价值选择,特别是在特定的患者群体中.
- 谨慎的患者选择和监测对于安全有效的使用至关重要.
- 需要进一步的研究和现实世界的数据来优化其应用.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
1.8K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
1.8K
Dysrhythmias VI: Management of Dysrhythmias
414
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
414
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
2.7K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
2.7K
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.5K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.5K
Dysrhythmias V: Evaluating Dysrhythmias
312
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
312
Dysrhythmias I: Introduction
507
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...
507


